Recurrent angioedema manifestation and treatment response in two patients from different families caring the myoferlin gene mutation: case series

Orphanet Journal of Rare Diseases, 2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1186/s13023-025-03932-9
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Data on hereditary angioedema with normal C1 inhibitor levels are currently limited. To date, only one Italian family with HAE-MYOF has been described, comprising exclusively female members. The angioedema (AE) of head and neck area with the teenage onset, triggered by menses and high fever episodes were identified. It is necessary to search for potential biomarkers in patients with HAE-MYOF. This case series reports two unrelated individuals from different families with symptoms onset of recurrent AE and identified myoferlin gene mutations. Due to limited knowledge about the clinical presentation, pathogenesis, and treatment response in HAE-MYOF, further data collection is essential.